These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1384523)

  • 21. Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens.
    Wang JT; Wang TH; Lin JT; Sheu JC; Lee CZ; Chen DS
    Vox Sang; 1992; 62(1):21-4. PubMed ID: 1374579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of three hepatitis C virus-related antibodies C100, KCL-163, JCC. Tests for screening blood donors.
    Fujiyama S; Kawano S; Sato S; Sato T; Kawahara T; Mizuno K; Kusumoto Y; Esumi M; Shikata T
    Dig Dis Sci; 1992 Oct; 37(10):1489-94. PubMed ID: 1382928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease.
    Brown J; Dourakis S; Karayiannis P; Goldin R; Chiba J; Ohba H; Miyamura T; Thomas HC
    Hepatology; 1992 Feb; 15(2):175-9. PubMed ID: 1370945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between first- and second-generation test for anti-hepatitis C virus antibodies in hemodialysis patients.
    Da Porto A; Poli P; Calzavara P; Castelletto MR; Adami A; Cascone C; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):367-8. PubMed ID: 1323794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of ELISA hepatitis C virus-positive blood donors population by polymerase chain reaction and recombinant immunoblot assay (RIBA). Comparison of second and third generation RIBA.
    Chicheportiche C; Cantaloube JF; Biagini P; Aumont P; Donnadieu F; Escher J; Larabi F; Zepitelli JP
    Acta Virol; 1993; 37(2-3):123-31. PubMed ID: 7692714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
    Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
    J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
    Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
    Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
    Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
    J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays.
    Couroucé AM; Le Marrec N; Girault A; Ducamp S; Simon N
    Transfusion; 1994 Sep; 34(9):790-5. PubMed ID: 8091469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibodies against hepatitis C virus. Experience with a second generation test].
    Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
    G E N; 1991; 45(3):183-9. PubMed ID: 1726913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved detection of antibodies to hepatitis C virus using a second generation ELISA.
    Lee S; McHutchinson J; Francis B; DiNello R; Polito A; Quan S; Nelles M
    Adv Exp Med Biol; 1992; 312():183-9. PubMed ID: 1381139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays.
    Lelie PN; Cuypers HT; Reesink HW; van der Poel CL; Winkel I; Bakker E; van Exel-Oehlers PJ; Vallari D; Allain JP; Mimms L
    J Med Virol; 1992 Jul; 37(3):203-9. PubMed ID: 1331309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative sensitivity of different solid-phase immunoassays for detecting HBsAg and anti-HCV in blood].
    León P; López JA; Domingo CJ; Echevarría JM
    Sangre (Barc); 1992 Oct; 37(5):407-10. PubMed ID: 1284096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anti-HCV and recipients: situation in hemophiliacs in 1991].
    Maisonneuve P; Couroucé AM; Ferrer le Coeur F; Guérois C; Laurian Y; Magniez M; Parquet-Gernez A; Verroust F; Noël L
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):193-8. PubMed ID: 1384524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
    Mattsson L; Grillner L; Weiland O
    Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
    Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
    Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors.
    Busch MP; Tobler L; Quan S; Wilber JC; Johnson P; Polito A; Steane E; Zola A; Bahl C; Nelles M
    Transfusion; 1993 Jan; 33(1):84-8. PubMed ID: 7678710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.